<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prognostic factors &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/prognostic-factors/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 25 Nov 2025 09:14:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Prognostic factors &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Comorbidities Influence Melanoma Patient Survival</title>
		<link>https://bioengineer.org/comorbidities-influence-melanoma-patient-survival/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 09:13:37 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Comorbidity clusters]]></category>
		<category><![CDATA[Comorbidity impact]]></category>
		<category><![CDATA[Latent class analysis]]></category>
		<category><![CDATA[Melanoma survival]]></category>
		<category><![CDATA[Prognostic factors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/comorbidities-influence-melanoma-patient-survival/</guid>

					<description><![CDATA[The rising incidence of cutaneous melanoma (CM) represents one of the most urgent challenges in oncology and public health today. Melanoma, known primarily for its aggressive nature and potential for rapid metastasis, poses substantial threats to patients worldwide. However, beyond the well-documented tumor biology and genetics, a crucial yet underexplored facet influencing patient outcomes lies [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300940</post-id>	</item>
	</channel>
</rss>
